AGM
GALT icon

Alpine Global Management’s Galectin Therapeutics GALT Stock Holding History

Alpine Global Management’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,555
Closed -$44.2K – 264
2024
Q2 		$44.2K Buy
+19,555
New +$59.4K 0.01% 445
2019
Q2 		– Sell
-19,093
Closed -$98K – 81
2019
Q1 		$98K Sell
19,093
-4,258
-18% -$20.4K 0.03% 86
2018
Q4 		$80K Buy
+23,351
New +$112K 0.02% 215
2015
Q3 		– Sell
-13,681
Closed -$37K – 372
2015
Q2 		$37K Buy
+13,681
New +$41.2K 0.01% 844

Other funds holding GALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return